Y Intercept (Hong Kong) LTD Veracyte, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 45,777 shares of VCYT stock, worth $1.21 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
45,777
Previous 21,361
114.3%
Holding current value
$1.21 Million
Previous $845,000
60.59%
% of portfolio
0.1%
Previous 0.06%
Shares
10 transactions
Others Institutions Holding VCYT
# of Institutions
306Shares Held
79.1MCall Options Held
15.5KPut Options Held
16.7K-
Vanguard Group Inc Valley Forge, PA8.26MShares$219 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$207 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$139 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.94MShares$104 Million1.26% of portfolio
-
Wellington Management Group LLP Boston, MA3.85MShares$102 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $1.9B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...